Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
The market of medicines in new members of European Union with population of 75 million people totaled in € 7 billions. The product patents were implemented during 1990’s in these countries. Patent protection is a key concern for research - based industry in unified market. In central and Eastern European markets the generics make about 70% of all medicines prescribed. The novelty on the market are “authorized generics”.
Biotechnologia, vol.76, 1 (2007)-.
0860-7796 ; oai:rcin.org.pl:87166 ; IChB B-72
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Oct 2, 2020
Dec 6, 2019
287
https://rcin.org.pl/publication/113567
Edition name | Date |
---|---|
The pharmaceutical industry, innovation, generics and competitiveness in the context of EU Enlargement | Oct 2, 2020 |
Sławińska, Anna Siwek, Maria
Tyczewska, Agata Bąkowska- Żywicka, Kamila
Pieczyński, Marcin Bielewicz, Dawid Dolata, Jakub Szweykowska-Kulińska, Zofia
Broniarczyk, Justyna Koczorowska, Maria Magdalena Durzyńska, Julia Warowicka, Alicja Goździcka-Józefiak, Anna